Evidence map›Paper›PMID 36233825›Full record

ArticleJournal of clinical medicine2022

Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.

Anna La Salvia, Raffaella Carletti, Monica Verrico, Tiziana Feola, Giulia Puliani, Massimiliano Bassi, Franz Sesti, Angelina Pernazza, Rossella Mazzilli, Giuseppe Lamberti and 11 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna La SalviaDivision of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0002-5020-8657
Raffaella CarlettiDepartment of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Monica VerricoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Tiziana FeolaDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1066-0064
Giulia PulianiDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-2899-9146
Massimiliano BassiDepartment of Thoracic Surgery, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.ORCID 0000-0002-2722-4974
Franz SestiDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-3850-627X
Angelina PernazzaDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.
Rossella MazzilliDepartment of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, 00185 Rome, Italy.
Giuseppe LambertiDepartment of Specialized, Experimental and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, 40126 Bologna, Italy.
Alessandra SicilianiDepartment of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University of Rome, 00185 Rome, Italy.
Massimiliano ManciniDivision of Morphologic and Molecular Sant'Andrea Hospital, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-7465-2229
Chiara ManaiDivision of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Federico VenutaDepartment of Thoracic Surgery, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.
Mohsen IbrahimDepartment of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University of Rome, 00185 Rome, Italy.
Silverio TomaoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Giulia D'AmatiDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-6959-691X
Cira Di GioiaDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-4696-0560
Elisa GiannettaDepartment of Experimental Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-3614-6151
Federico CappuzzoDivision of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Antongiulio FaggianoDepartment of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9324-3946

Funding

research was partially funded by a grant from the Italian Ministry of Education, Research and University (PRIN 2017Z3N3YC). PRIN 2017Z3N3YC
6 · The paper itself

Abstract

Well-differentiated lung neuroendocrine tumours (Lu-NETs), classified as typical (TC) and atypical (AC) carcinoids, represent 30% of NETs. Angiogenesis plays an essential role in NET development and progression. A higher vascular network is a marker of differentiation, with positive prognostic implications. Materials and Methods: We retrospectively evaluated microvessel density (MVD) by CD34 immunohistochemical (IHC) staining and hypoxia by IHC staining for Hypoxia-inducible factor 1α (HIF-1α), comparing right- and left-lung parenchyma in 53 lung NETs. Results: The median age was 66 years (39−81), 56.6% males, 24.5% AC, 40.5% left-sided tumours and 69.8% TNM stage I. The mitotic count was <2/10 per 10 HPF in 79.2%, and the absence of necrosis in 81.1%, 39.6% with Ki67, was ≤2%. The MVD, the number of vessels and the average vessel area median values were significantly higher in the right than the left parenchyma (p: 0.025, p: 0.019, p: 0.016, respectively). Hypoxia resulted present in 14/19 (73.6%) left tumours and in 10/20 (50%) right tumours in the parenchyma (p: 0.129). Conclusions: This study suggests a biological rationale for a different angiogenesis and hypoxia according to the Lu-NETs’ location. In our study, left primary tumours were less vascularized and most likely to present hypoxia than right primary tumours. This finding could have potentially useful prognostic and predictive implications for Lu-NETs.

Indexed as

angiogenesishypoxialeft sidelung NETnecrosisneuroendocrine tumoursprognostic factors

Identifiers

PMID36233825
PMCPMC9570740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.